Gene · 28402
Papers3,091
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
781 to 800 of 3,091
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Cancer-Cell-Derived IgG and Its Potential Role in Tumor Development. | Int J Mol Sci | 2021 | 34769026 | PubTator, text mining | PubMed |
| Treatment Options for Elderly/Unfit Patients with Chronic Lymphocytic Leukemia in the Era of Targeted Drugs: A Comprehensive Review. | J Clin Med | 2021 | 34768624 | PubTator, text mining | PubMed |
| The Hydropathy Index of the HCDR3 Region of the B-Cell Receptor Identifies Two Subgroups of IGHV-Mutated Chronic Lymphocytic Leukemia Patients With Distinct Outcome. | Front Oncol | 2021 | 34765543 | PubTator, text mining | PubMed |
| AI applications in functional genomics. | Comput Struct Biotechnol J | 2021 | 34765093 | PubTator, text mining | PubMed |
| Secondary Immunodeficiency in Hematological Malignancies: Focus on Multiple Myeloma and Chronic Lymphocytic Leukemia. | Front Immunol | 2021 | 34759921 | PubTator, text mining | PubMed |
| The Role of BTK Inhibition in the Treatment of Chronic Lymphocytic Leukemia: A Clinical View. | J Exp Pharmacol | 2021 | 34744463 | PubTator, text mining | PubMed |
| COVID-19 severity and mortality in patients with CLL: an update of the international ERIC and Campus CLL study. | Leukemia | 2021 | 34725454 | PubTator, text mining | PubMed |
| Survival of patients with chronic lymphocytic leukemia before and after the introduction of chemoimmunotherapy in Germany. | Blood Cancer J | 2021 | 34716290 | PubTator, text mining | PubMed |
| Germline polymorphisms and alternative splicing of human immunoglobulin light chain genes. | iScience | 2021 | 34693229 | PubTator, text mining | PubMed |
| Richter Transformation in Chronic Lymphocytic Leukemia: Update in the Era of Novel Agents. | Cancers (Basel) | 2021 | 34680290 | PubTator, text mining | PubMed |
| Frontline Treatment of the Young, Fit Patient with CLL: A Canadian Perspective. | Curr Oncol | 2021 | 34677244 | PubTator, text mining | PubMed |
| COVID-19 Lung Pathogenesis in SARS-CoV-2 Autopsy Cases. | Front Immunol | 2021 | 34671353 | PubTator, text mining | PubMed |
| Computational Inference, Validation, and Analysis of 5'UTR-Leader Sequences of Alleles of Immunoglobulin Heavy Chain Variable Genes. | Front Immunol | 2021 | 34671351 | PubTator, text mining | PubMed |
| An Aggressive Presentation of Mantle Cell Lymphoma With Unique Molecular Features. | Cureus | 2021 | 34646650 | PubTator, text mining | PubMed |
| Towards a Better Characterisation of Leukemic Cells in Chronic Lymphocytic Leukaemia: Cell-Size Heterogeneity Reflects Their Activation Status and Migratory Abilities. | Cancers (Basel) | 2021 | 34638404 | PubTator, text mining | PubMed |
| Sensitivity of SARS-CoV-2 Variants to Neutralization by Convalescent Sera and a VH3-30 Monoclonal Antibody. | Front Immunol | 2021 | 34630430 | PubTator, text mining | PubMed |
| Detailing the epidemiological and clinical characteristics of chronic lymphocytic leukaemia in Portugal-Results from a population-based cancer registry cohort study. | PLoS One | 2021 | 34624053 | PubTator, text mining | PubMed |
| Differential Levels of mRNAs in Normal B Lymphocytes, Monoclonal B Lymphocytosis and Chronic Lymphocytic Leukemia Cells from the Same Family Identify Susceptibility Genes. | Oncol Ther | 2021 | 34622420 | PubTator, text mining | PubMed |
| Ibrutinib Plus Venetoclax for First-Line Treatment of Chronic Lymphocytic Leukemia: Primary Analysis Results From the Minimal Residual Disease Cohort of the Randomized Phase II CAPTIVATE Study. | J Clin Oncol | 2021 | 34618601 | PubTator, text mining | PubMed |
| Follicular lymphoma subgroups with and without t(14;18) differ in their N-glycosylation pattern and IGHV usage. | Blood Adv | 2021 | 34614504 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/28402/papers?page=40